Cognitive Control Training
BehavioralThe five intervention groups will receive either 1, 5, 10, 15 or 20 training sessions with the Adaptive Paced Auditory Serial Addition Task (aPASAT).
NCT Number: NCT05166798
This study aims to examine the dose-response relationship of an online adaptive cognitive control training on depressive symptomatology and rumination. Participants will be randomized over six groups, each receiving a different dose (0, 1, 5, 10, 15 or 20 sessions) of a cognitive control training in remitted depressed patients. An adaptive Paced Auditory Serial Addition Task will be used as cognitive control training.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Ghent University, Ghent, Oost-Vlaanderen, Belgium
Depression is often associated with cognitive impairments and recent studies have found that for some people, these cognitive problems persist after remission of depression. These cognitive impairments could be a risk factor for recurrence of depressive episodes. Cognitive control training aims to address these cognitive impairments and decrease the risk of recurrence of depression.
One promising operationalization of cognitive control training is the adaptive Paced Auditory Serial Addition Task, but currently, it's unclear how many sessions one should complete in order to obtain cognitive- and emotional transfer effects. By comparing multiple groups with a different number of sessions (0, 1, 5, 10, 15 and 20), with measures at post (one month after baseline) and two follow-up periods (at 3 months and 6 months after baseline), this study examines the effects of an online cognitive control training on depressive vulnerability factors.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The five intervention groups will receive either 1, 5, 10, 15 or 20 training sessions with the Adaptive Paced Auditory Serial Addition Task (aPASAT).
Time frame: baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Self-report questionnaire with 21 items, depression symptom severity, scores can range from 0 to 63, with higher scores indicating more severe depression.
Time frame: baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Change from baseline in perseverative thinking. The PTQ-NL consist of 15 items and are assessed using scores ranging from 0 (never) to 4 (almost always). Lower scores indicate lower levels of preservative thinking.
Time frame: baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Self-reported measure for emotion regulation: a 36-item questionnaire, consisting of 9 subscales (Self-blame, Other-blame, Rumination, Catastrophizing, Putting into Perspective, Positive Refocusing, Positive Reappraisal, Acceptance and Planning). Each item is rated on a 1 to 5 scale (1 = almost never and 5 = almost always). Higher subscale scores represent more frequent use of a specific cognitive strategy.
Time frame: baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
Measured by the subscale Effortful Control (EC) from the Adult Temperament Questionnaire (ATQ).
Time frame: baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
The Burnout Assessment Tool (BAT) is used to assess burn-out risk. The score ranges from 1 to 5, with higher scores indicating a higher risk of burn-out.
Time frame: baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
The Remission from Depression Questionnaire has 41 items, which assess domains such as positive mental health, life satisfaction, and sense of well-being. The items are scored 0 (not at all or rarely true), 1 (sometimes true) or 2 (often or almost always true).
Time frame: baseline, post training (one month after baseline), 3 month follow-up after baseline, 6 month follow-up after baseline
A non-adaptive computerized version of the Paced Auditory Serial- Addition Task (PASAT) was used as a measure of participants' working memory abilities. Higher accuracy scores suggest greater cognitive control resources.
Time frame: baseline, post training (one month after baseline)
The n-back task is a classic cognitive working memory task during which participants are asked to decide if a digit appearing on a screen is the same as the digit that appeared n stimuli earlier (n-back).
Time frame: 3 month follow-up after baseline, 6 month follow-up after baseline
In the LTE questionnaire, unpleased life events are listed and participants are asked if these events occurred recently. The LTE-Q contains 13 items for which "yes" or "no" are the two possible answers.
Time frame: baseline, post training (one month after baseline)
The 6-item CEQ measures ratings of treatment credibility, acceptability/satisfaction, and expectations for success.
University Ghent
Other
Establishing a Dose-response Relationship for the Effects of a Cognitive Control Training on Depression Vulnerability
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03278756
Behavior, Behavioral Symptoms
Ghent, Oost-Vlaanderen, Belgium
View Trial DetailsNCT04864353
Cognition Disorders, Cognitive Dysfunction
Bergen, Norway
View Trial DetailsNCT02407652
Major Depression in Remission
Ghent, Oost-Vlaanderen, Belgium
View Trial DetailsNCT04325529
Major Depression in Remission
Belmont, Massachusetts, United States
View Trial Details